AstraZeneca reviews

Zero job security for US employees (non-Oncology, non-Biologics), the recurring and shortening cycle of downsizing has taken a toll on morale. Compounds coming through pipeline are promising, but not necessarily first-in-class presenting uptake challenges for commercialization. The headcount reductions have left those remaining with implicit expectations to manage/deliver with less resources. Headcount reductions have resulted in valued employees being cut due to 'strategic realignment'; dead wood was trimmed long ago, it's now trimming 'green branches on the tree' - leadership probably would not prefer such options, but it is a sign of the breadth and depth of the financial issues the company faces in order to deliver on financial objectives for shareholders.

-If you just want a job this is a good place but if you want to grow,this is not the place for you. -Middle managers are incompetent and are least bothered about developing their reports.Too much favoritism exists -It is very hard to even make lateral moves. -Managers are unprofessional -Performance reviews and promotions are illogical.Managers have way too much power in their hands and can make your life miserable if they don't like you.